Search · The Cardiovascular

TheCardiovascular

Log in Become a member

60+ träffar

KVÅKVÅ

3E0U328 — Introduction of Oxazolidinones into Joints, Percutaneous Approach

KVÅKVÅ

3E0U028 — Introduction of Oxazolidinones into Joints, Open Approach

KVÅKVÅ

3E00X28 — Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach

KVÅKVÅ

3E01328 — Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach

KVÅKVÅ

3E02328 — Introduction of Oxazolidinones into Muscle, Percutaneous Approach

KVÅKVÅ

3E03028 — Introduction of Oxazolidinones into Peripheral Vein, Open Approach

KVÅKVÅ

3E03328 — Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach

KVÅKVÅ

3E04028 — Introduction of Oxazolidinones into Central Vein, Open Approach

KVÅKVÅ

3E04328 — Introduction of Oxazolidinones into Central Vein, Percutaneous Approach

KVÅKVÅ

3E05028 — Introduction of Oxazolidinones into Peripheral Artery, Open Approach

KVÅKVÅ

3E05328 — Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach

KVÅKVÅ

3E06028 — Introduction of Oxazolidinones into Central Artery, Open Approach

KVÅKVÅ

3E06328 — Introduction of Oxazolidinones into Central Artery, Percutaneous Approach

KVÅKVÅ

3E09328 — Introduction of Oxazolidinones into Nose, Percutaneous Approach

KVÅKVÅ

3E09728 — Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening

KVÅKVÅ

3E09X28 — Introduction of Oxazolidinones into Nose, External Approach

KVÅKVÅ

3E0B328 — Introduction of Oxazolidinones into Ear, Percutaneous Approach

KVÅKVÅ

3E0B728 — Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening

KVÅKVÅ

3E0BX28 — Introduction of Oxazolidinones into Ear, External Approach

KVÅKVÅ

3E0C328 — Introduction of Oxazolidinones into Eye, Percutaneous Approach

KVÅKVÅ

3E0C728 — Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening

KVÅKVÅ

3E0CX28 — Introduction of Oxazolidinones into Eye, External Approach

KVÅKVÅ

3E0D328 — Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach

KVÅKVÅ

3E0D728 — Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening

KVÅKVÅ

3E0DX28 — Introduction of Oxazolidinones into Mouth and Pharynx, External Approach

KVÅKVÅ

3E0E328 — Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach

KVÅKVÅ

3E0E728 — Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening

KVÅKVÅ

3E0E828 — Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0F328 — Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach

KVÅKVÅ

3E0F728 — Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening

KVÅKVÅ

3E0F828 — Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0G328 — Introduction of Oxazolidinones into Upper GI, Percutaneous Approach

KVÅKVÅ

3E0G728 — Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening

KVÅKVÅ

3E0G828 — Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0H328 — Introduction of Oxazolidinones into Lower GI, Percutaneous Approach

KVÅKVÅ

3E0H728 — Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening

KVÅKVÅ

3E0H828 — Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0J328 — Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach

KVÅKVÅ

3E0J728 — Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

KVÅKVÅ

3E0J828 — Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0K328 — Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach

KVÅKVÅ

3E0K728 — Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening

KVÅKVÅ

3E0K828 — Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0L328 — Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach

KVÅKVÅ

3E0M328 — Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach

KVÅKVÅ

3E0N328 — Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach

KVÅKVÅ

3E0N728 — Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening

KVÅKVÅ

3E0N828 — Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0P328 — Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach

KVÅKVÅ

3E0P728 — Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening

KVÅKVÅ

3E0P828 — Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0Q028 — Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach

KVÅKVÅ

3E0Q328 — Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach

KVÅKVÅ

3E0R328 — Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach

KVÅKVÅ

3E0S328 — Introduction of Oxazolidinones into Epidural Space, Percutaneous Approach

KVÅKVÅ

3E0V328 — Introduction of Oxazolidinones into Bones, Percutaneous Approach

KVÅKVÅ

3E0W328 — Introduction of Oxazolidinones into Lymphatics, Percutaneous Approach

KVÅKVÅ

3E0Y328 — Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach

KVÅKVÅ

3E00X05 — Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach

KVÅKVÅ

3E00X0M — Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach